Waiting for Answers<br />By Rev Shark<br />RealMoney.com Contributor<br />2/6/2009 8:36 AM EST <br /><br />He must be very ignorant, for he answers every question he is asked. <br />-- Voltaire<br /><br />The market awaits the latest round of government answers to our economic woes. An economic stimulus bill should be passed shortly, and a bank bailout scheme is set to be announced Monday evening. In the meanwhile, we have the monthly jobs data, which are expected to reflect another increase in unemployment. <br /><br />The question for investors is whether the market is going to embrace the governmental moves as effective solutions and finally generate a bit of a bear-market rally. So far, every prior program proposed has given us nothing more than a short-lived pop that eventually led to more downside. Unlike the latest bailout and bank programs which are highly anticipated the past moves by the Fed and the Treasury held some real surprises. That doesn't bode particularly well for a sustained rally on the news announcements. <br /><br />Unemployment news is expected to be brutally ugly once again, but the market has been expecting all economic news to be poor and is inclined to buy weakness rather than panic. Buying bad news is a good sign, as it shows that expectations are low, but the market also needs some real positives as well to generate some lasting momentum. We continue to have an absolute dearth of anything that sounds very good. We have things like JPMorgan lowering the target of GE (GE) to $9 from $13 and talking about a credit downgrade and a big surprise in increased Canadian unemployment. <br /><br />The problem we face is that there is that the market has already had plenty of time to consider what bailout and banking news is coming and doesn't seem to be overly confident about it. We'll see what happens after the jobs numbers are out. I'm looking for a few spikes of excitement as terms of the bank bill are leaked, but I suspect the market will remain skeptical and will have a tendency to sell off once the news is finally out by Tuesday morning. A lot depends on how we set up as we wait, but this sort of highly anticipated news event is not something that lends itself to a sustainable rally. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: BECN +17.6%, TSYS +14.5%, SNCR +12.4% (also upgraded to Accumulate from Source of Funds at ThinkEquity), DKS +12.3%, PBI +10.8%, SWKS +10.6% (also upgraded to Buy from Accumulate at ThinkEquity), AMX +2.2%, APKT +1.3% (also upgraded to Accumulate from Source of Funds at ThinkEquity)... Select financials showing continued strength: RBS +7.9%, BCS +7.2%, RF +7.1%, HBC +4.5%, BAC +4.3% (BofA is cash flow positive and not in danger of failure- Ladenburg Thalman), C +3.4%, MS +3.1%, BBT +2.7%, WFC +2.6%, BK +2.6%, JPM +1.6%, GS +1.5%... Select stem cell related names trading higher with Washington Times reporting that Obama 'guarantees' stem cell approval: ASTM +12.5%, STEM +9.8%, GERN +3.2%... Select drybulk shippers showing continued strength: EXM +5.7%, DRYS +4.8%, GNK +4.2%... Select metals/mining names trading higher: AU +3.9%, FCX +2.9%, MT +2.5% (denies intention to sell Brazilian assets - DJ), RTP +1.7%, RIO +1.7%... Other news: DAI +5.6% (still checking for anything specific), IDIX +4.8% (Idenix Pharmaceuticals and GlaxoSmithKline sign worldwide license agreement for IDX899, a novel NNRTI for the treatment of HIV), DLTR +3.3% (modestly rebounding from yesterday's 10%+drop)... Analyst comments: AKAM +3.1% (initiated with Buy at Wunderlich).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: SKX -22.2% (downgraded to Neutral from Positive at Susquehanna Financial and downgraded to Hold at Sterne Agee), HIG -19.9%, MFLX -13.2%, HWAY -11.9% (also downgraded to Sell from Neutral at Piper Jaffray), RATE -11.2%, ESLR -9.9% (also downgraded to Neutral at Piper), ULTI -9.8% (light volume), LMNX -9.0%, AINV -7.3% (light volume), SRCL -6.5%, BIIB -6.2%, VRSN -6.0%, JDSU -4.9% (also downgraded to Underperform from Sector Perform at RBC Capital Mkts), LQDT -1.9%... Select insurer-related names ticking lower in sympathy with HIG results: LNC -3.8%, ALL -2.8%, MET -2.2% (downgraded to Neutral at BofA/Merrill), GNW -1.7% ... Other news: ELN -8.2% (trading down in sympathy with BIIB), NMR -5.1% (to raise up to $3.3 bln in shares - Reuters), UBS -4.7% (still checking), QGEN -4.1% (still checking), AZN -2.1% (still checking), APOL -1.2% (Cramer makes negative comments on MadMoney)... Analyst comments: CUB -2.4% (downgraded to Hold at Needham), STO -2.0% (downgraded to Hold at Citigroup), ABMD -1.9% (downgraded to Neutral at UBS and downgraded to Equal Weight at Morgan Stanley).